Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × marizomib × Other solid neoplasm × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 2 Dermatologic 2 CNS 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Interventions

Injections 80 pembrolizumab 79 Paclitaxel 53 Carboplatin 53 Cisplatin 48 Docetaxel 40 Nivolumab 36 Pemetrexed 34 Gemcitabine 34 atezolizumab 28 Bevacizumab 28 tislelizumab 27 Fluorouracil 23 Irinotecan 20 Capecitabine 20 toripalimab 18 Oxaliplatin 17 Leucovorin 17 Ipilimumab 17 Cetuximab 16 durvalumab 15 olaparib 13 Rifampin 12 Itraconazole 12 Midazolam 11 Cyclophosphamide 11 trifluridine tipiracil drug combination 10 spartalizumab 10 sintilimab 9 linifanib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04644107 2020-11-25

Expanded Access for Marizomib

Celgene

No longer available

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡